IL17A and cancer: Recently, some review papers providing new insight into Th17 have published, such as human cancer-associated immunity [36], Th17 expressing CD161 and interleukin-4-induced gene 1; Th17 function markers [37] and humanized anti-IL-17A monoclonal antibody [38].